Why Comprehensive Analytical Services are Core to the Future of Antibody-Drug Conjugates
Abstract: As antibody-drug conjugates (ADCs) grow more complex, comprehensive analytical services are becoming central to successful development from discovery through commercialization. A phase-appropriate ADC analytical strategy helps developers characterize critical quality attributes early, resolve the interplay between molecular structure and function, mitigate development and regulatory risk, and generate the robust data that supports efficient manufacturing and regulatory success.